New clues to hepatitis B species restriction could help build a novel model for studying infection and testing therapies
April 22, 2026
April 22, 2026
NEW YORK, April 22 -- Rockefeller University posted the following news:
* * *
New clues to hepatitis B species restriction could help build a novel model for studying infection and testing therapies
*
Some 254 million people live with a chronic hepatitis B (HBV) infection that is often asymptomatic for decades, only to emerge in an advanced stage of disease that turns to fatal cirrhosis or liver cancer in nearly a million people every year.
* * *
New clues to hepatitis B species restriction could help build a novel model for studying infection and testing therapies
*
Some 254 million people live with a chronic hepatitis B (HBV) infection that is often asymptomatic for decades, only to emerge in an advanced stage of disease that turns to fatal cirrhosis or liver cancer in nearly a million people every year.